InsidersTradesSigma
Track the Seaport Therapeutics, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €1.3bn. The latest transaction was reported on 24 June 2026 (Acquisition). Among the most active insiders: HOMBACH ROBERT J.. Every trade is openly available.
Analysts rate Seaport Therapeutics, Inc. Strong Buy (bullish), based on 5 analysts. Average price target: US$38.00.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Seaport Therapeutics, Inc. es una empresa centrada en el desarrollo de terapias innovadoras. Se especializa en la investigación y comercialización de tratamientos para enfermedades graves.